JPS5777621A - Anti-tumor agent - Google Patents

Anti-tumor agent

Info

Publication number
JPS5777621A
JPS5777621A JP55152231A JP15223180A JPS5777621A JP S5777621 A JPS5777621 A JP S5777621A JP 55152231 A JP55152231 A JP 55152231A JP 15223180 A JP15223180 A JP 15223180A JP S5777621 A JPS5777621 A JP S5777621A
Authority
JP
Japan
Prior art keywords
tumor
effective
cyclophosphamide
low
tumor agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP55152231A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6241568B2 (cg-RX-API-DMAC7.html
Inventor
Masahiko Mutai
Teruo Yokokura
Ikuo Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Priority to JP55152231A priority Critical patent/JPS5777621A/ja
Publication of JPS5777621A publication Critical patent/JPS5777621A/ja
Publication of JPS6241568B2 publication Critical patent/JPS6241568B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP55152231A 1980-10-31 1980-10-31 Anti-tumor agent Granted JPS5777621A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55152231A JPS5777621A (en) 1980-10-31 1980-10-31 Anti-tumor agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55152231A JPS5777621A (en) 1980-10-31 1980-10-31 Anti-tumor agent

Publications (2)

Publication Number Publication Date
JPS5777621A true JPS5777621A (en) 1982-05-15
JPS6241568B2 JPS6241568B2 (cg-RX-API-DMAC7.html) 1987-09-03

Family

ID=15535950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55152231A Granted JPS5777621A (en) 1980-10-31 1980-10-31 Anti-tumor agent

Country Status (1)

Country Link
JP (1) JPS5777621A (cg-RX-API-DMAC7.html)

Also Published As

Publication number Publication date
JPS6241568B2 (cg-RX-API-DMAC7.html) 1987-09-03

Similar Documents

Publication Publication Date Title
MY102378A (en) Transdermal delivery system.
Hirt et al. Induction of interferon production in mouse spleen cell cultures by Corynebacterium parvum
EP0217206A3 (en) Medicament against chronic graft-versus-host diseases, as well as against autoimmune diseases, particularly systemic lupus erythematodes
JPS55122717A (en) Interferon inducer
Spitzer et al. High-dose BCNU therapy with autologous bone marrow infusion: preliminary observations
UA41285C2 (uk) Креатин фосфат і його фармацевтично прийнятні солі для лікування пухлин та фармацевтична композиція, що має протипухлинну активність
UA27704C2 (uk) Спосіб здійснення хіміотерапії
EP0227844A4 (en) Antiviral drug.
JPS5777621A (en) Anti-tumor agent
CA2041380A1 (en) Use of protein c or activated protein c for preparing a pharmaceutical preparation
EP0334967A4 (en) Keratosis-treating agent
JPS57106618A (en) Anticancer agent consisting of polyprenyl compound
KR900701301A (ko) 후천성 면역 결핍증과 연관된 골수억제증의 치료방법
JPS55122721A (en) Antidiabetic agent
JPS5540635A (en) Remedy for cardiac insufficiency
Amano et al. Clinical studies on combination chemotherapy with fosfomycin and dibekacin in complicated urinary tract infection
IE35711B1 (en) Pharmaceutical composition for inhibiting indoleamine-n-methyl transferase
JPS56110622A (en) Carcinostatic agent
Mordarski et al. Antibiotics produced by Streptomyces olivaceus 142. III. Influence of antibiotic Wr 142 FPG on development of transplantable tumors in mice
Gresser Usefulness of the Results of Studies on the Antitumor Effects of Interferon in Animals to Interferontherapy of Patients
IE33519L (en) Benzylhydrazides
JPS57179118A (en) Antitumor agent
GB1316006A (en) Pharmaceutically active chemical compound and an antitumourigenic preparation containing same
GB1230681A (cg-RX-API-DMAC7.html)
GB1050396A (cg-RX-API-DMAC7.html)